Rimonabant May Reduce Weight and Cardiovascular Risk Factors

The investigators in this randomized trial suggest that rimonabant has a favorable safety profile and holds therapeutic promise for the treatment of obesity and associated risk factors. (CME)
Medscape Medical News
Charles Vega,Gary Vogin,Laurie Barclay